Aditxt, Inc. Public Float
Aditxt, Inc. (ADTX) had Public Float of $4.32 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $4.32M.
- 2024-06-30: Entity Public Float $2.73M.
- 2023-06-30: Entity Public Float $3.01M.
- 2022-06-30: Entity Public Float $7.92M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.32M 10-K · filed 2026-03-31 |
| 2024-06-30 | $2.73M 10-K · filed 2025-03-31 |
| 2023-06-30 | $3.01M 10-K · filed 2024-04-16 |
| 2022-06-30 | $7.92M 10-K/A · filed 2023-07-12 |
| 2021-06-30 | $32.73M 10-K/A · filed 2022-04-15 |
| 2020-06-30 | $20.08M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |